There has been remarkable progress in confronting the global HIV epidemic. More than 19.5 million people living with HIV (PLHIV) have received access to antiretroviral therapy, and the number of new HIV infections appears to be decreasing in several countries . Investments in research, particularly in identifying effective HIV prevention and treatment methods, have played a significant role in this success . As the scale-up of HIV treatment has enabled PLHIV to live longer, noncommunicable diseases (NCDs), often referred to as non-AIDS events, have become major causes of morbidity and mortality [2–4]. This new reality is consistent with the overall emerging crisis of NCDs in sub-Saharan Africa (SSA) . In response, global health agencies, such as the WHO and the Joint United Nations Program on HIV/AIDS, have recently called for eliminating parallel health systems and suggested integrating care for NCDs into existing HIV care platforms, and the Council on Foreign Relations suggested that HIV platforms could be expanded to include treatment for NCDs [5–7]. This particular approach to developing an enhanced health system avoids making duplicate platforms by creating one that applies the lessons learned from HIV care and treatment to NCDs. To address the developing threat of NCDs among PLHIV through integrated HIV/NCD care, programs need new evidence-based models and guidance. Little is known about the extent to which NCDs are being managed in HIV care settings and what needs to be done to ensure that such care is delivered. In response, we designed a consensus process to assess current evidence and experience and to establish a research agenda for enhancing NCD management in HIV care settings in SSA.
The Center for Global Health Studies at the US National Institutes of Health's (NIH) Fogarty International Center (FIC) established an interagency, interdisciplinary team to develop a research agenda focused on the prevention and management of selected, high-burden NCDs in PLHIV in SSA. This effort entitled, ‘Research to Guide Practice: Enhancing HIV/AIDS Platforms to Address NCDs in SSA’ (the HIV/NCD project), was managed through an interagency group and guided by an interdisciplinary, international Steering Committee led by select members of the FIC Advisory Board. More than 40 individuals (project members) involved in global health research, policy development, community engagement, research funding, and program design and management in SSA countries provided input on currently available evidence regarding prevention, care, and treatment for HIV and four selected NCDs in SSA: cardiovascular diseases, cervical cancer, depression, and type 2 diabetes. These NCDs were selected based on the following: available data of the condition or related risk factors in PLHIV; known patho-physiological connection with HIV; association with reported HIV outcomes including morbidity and mortality amongst PLHIV; known cost-effective interventions to prevent and treat the selected NCD in low-resource settings [8–16]; and NIH institute interest in and ability to engage specific areas of focus. Although the focus of this effort was on countries in SSA, it was anticipated that the lessons and strategies that emerge from these countries will likely be relevant to other low-resource settings globally.
Through a process outlined in Table 1, we performed literature reviews and conducted priority setting meetings and workshops culminating with the writing and publication of the articles in this supplement: Research to Guide Practice: Enhancing HIV/AIDS Platform to Address Non-Communicable Diseases in sub-Saharan Africa. Project members conducted scoping reviews of what is currently being done in the field of NCD prevention, care, and treatment for PLHIV in SSA by examining peer-reviewed and gray literature focused on the four selected NCDs . We searched the bibliographic databases PubMed/MEDLINE and Scopus in February, April, and November of 2015, and March of 2016 to identify peer-reviewed literature, published after 2010, on PLHIV and NCDs in low-income and middle-income countries. Search terms used included controlled vocabulary terms (Medical Subject Headings) and keywords recommended by subject matter experts and by reviewing key articles and included variations of key concepts such as PLHIV, NCDs, SSA, continuum of care, prevalence, health systems, behavior change, and dissemination. In addition to literature searches, the bibliographies of key articles and systematic reviews were examined for relevant literature, and gray literature was identified via searches of Google, Google Scholar, and key organizational websites. Project members reviewed the relevant articles related to the four NCDs of interest among PLHIV. The resulting analysis reported and identified gaps for integration of NCDs into the HIV clinical continuum of care, piloting and scaling-up an integrated chronic care health system, and enhancing HIV/NCD community engagement and health promotion efforts.
Project members examined the scoping reviews and identified research gaps that informed the development of the prioritized research agenda presented in this article. Through the analysis and discussion, they identified pilot HIV/NCD programs in SSA that were critically examined at a subsequent workshop as potential scalable models. The result of the reviews, workshop, and supplement planning is a series of 11 articles developed by the project members and their collaborators that articulate the urgent research and capacity-building priorities associated with managing NCDs among PLHIV. Each article presents the state of the science, lessons learned, and key research questions pertaining to specific aspects of building and sustaining an integrated chronic care platform .
The scoping reviews identified substantial gaps in knowledge and significant opportunities for future research to determine the most effective way to integrate NCD management into existing HIV platforms. One important finding was that data on the prevalence and incidence of NCDs amongst PLHIV in SSA are sparse. Although there are a few published surveys establishing the prevalence of NCDs and related risk factors in the general population  and even fewer surveys that have routinely gathered NCD incidence or risk factor prevalence among PLHIV, there is some available information on these NCDs and their risk factors among PLHIV in SSA . Policymakers and implementers reinforced the need for these data to obtain unbiased estimates of the magnitude of the NCD threat in PLHIV, without which it is difficult to assess the size of the needed investment in NCD for PLHIV or to determine any progress made once such care is initiated .
Members determined that HIV treatment strategies can incorporate NCDs to improve clinical outcomes and primary and secondary prevention for both HIV and NCDs. Although the gradual rise of global NCDs presents a different scenario than the swift and deadly global HIV epidemic, members found that the systems required to address both chronic infections such as HIV and noninfectious chronic diseases have common elements that could leverage existing health system structures heretofore focused solely on HIV prevention and treatment. The review also noted that there were few published studies that described programs that integrated HIV and NCD care which makes it difficult to extrapolate the results to policy recommendations for scale-up. Much research is needed in this area. Recognizing that integrating HIV and NCD services at scale requires leveraging the underlying health system structures, project members further identified the research priorities related to various health system components in SSA including the health workforce , supply chain , health promotion , healthcare delivery models , cost and cost-effectiveness , and health policy .
Another key finding is the need for ongoing engagement between research and programs/policies that will ensure that there is adequate knowledge exchange such that studies take into account the concerns and experiences of implementers and policymakers and research results are translated into new care paradigms. In addition, community and patient engagement is critical to ensuring that implemented activities are acceptable to and embraced by the key stakeholder population. Efforts to combat the global HIV epidemic have relied upon collaborative partnerships and provide many lessons learned about how to form and maintain these collaborations . Thus, implementation science, which relies on key stakeholder involvement, provides an opportunity to study HIV/NCD integration activities in real-world settings and at scale .
As an outcome of both the scoping reviews and the articles included in the supplement, members developed robust research agendas that outline the fundamental areas for future development (Table 2). This agenda is presented through a modification of WHO's health system building blocks (Fig. 1) that represents the foci of research activities necessary for developing an integrated chronic care platform.
The identified research questions map across these health system building blocks and include questions that are cross-cutting in nature. Table 2 outlines the research agenda initially developed through the scoping reviews and project member discussions and the set of research questions from each article in the supplement. These questions fall into four thematic areas:
- Burden of disease data of NCDs among PLHIV to understand the magnitude of the current and ongoing chronic care needs and make the case for integrated screening and treatment.
- Implications of effective chronic care integration across the health system, including evidence for point-of-care NCD prevention, care, and treatment, implementation and scale-up of services, modifying underlying health system structures, and policy initiatives to enhance sustainability.
- Implementation science advances and capacity to answer research questions related to integration and assess effective approaches to evolving NCD care for PLHIV.
- Partnership and stakeholder engagement, especially national government agencies, in the research agenda to ensure responsive and continuous services for integrated chronic care.
As countries seek to address the growing NCD epidemic in SSA, new evidence to address gaps in knowledge is urgently needed. If implemented, the research agenda we propose aims to generate this evidence across critical areas of the health system to enable evidence-informed scale up of HIV/NCD care services for PLHIV. We believe that this research will also be relevant to and inform chronic care for the general population beyond PLHIV. For instance, the development of a reliable supply chain that can accommodate diagnostic and treatment supplies for a myriad of conditions beyond HIV could be scaled up to the general population. Likewise, a health workforce capable of caring for NCDs among PLHIV could also address chronic diseases in the general population.
The diversity of research questions identified through the HIV/NCD Project requires the engagement of a wide range of scientific disciplines, including clinical research, healthcare management science, health economics, behavioral and communications science, health systems research, policy research, information technology, and epidemiology and surveillance. Implementation science will play a key role in informing efforts to effectively integrate known services and bring such innovations to scale.
There are encouraging signs of efforts to address some of the questions identified in the research agenda. Several NIH institutes and centers, including the National Institute of Mental Health, the National Cancer Institute, the National Heart, Lung and Blood Institute, and the FIC, all members of this project, have established funding announcements and notices that provide support to answer the key questions in the research agenda [30–32].
Additional engagement and support from all relevant stakeholders, including funding agencies, researchers, program implementers, the community, multilateral organizations, and policymakers are needed to systematically answer the many critical questions that stand in the way of moving the integration efforts forward. Timely dissemination of the research results will promote quick uptake of the evidence to inform policies and programs. At all levels – national, international, and multilateral – partnerships need to be established to address the dual challenges of HIV and NCDs. Many of the innovative partnerships developed for the HIV epidemic provide opportunities to evaluate lessons learned that could be applicable to NCD care. Other partnerships may need to be re-envisioned for NCDs and new mechanisms may need to be established.
As efforts continue to address the threat of NCDs among PLHIV, much can be done to build upon the investments to date in strengthening the HIV platform. Implementation of integrated chronic care is critical to sustain the public health gains made through investments in HIV prevention and care. This holistic approach has potential benefits for both HIV and NCD prevention and treatment. However, many gaps in knowledge stand in the way of progress, and policymakers need a solid evidence base to inform their decision-making. The research agenda developed by this HIV/NCD project offers a pathway forward that can serve as a roadmap for funders, policymakers and researchers.
W.M.E-S. and L.K. provided initial conceptualization; S.V., P.P., and L.K. drafted the article; S.V., P.P., and B.B. provided the chart of research questions; P.P., N.A., W.M.T., and R.F. along with all other authors reviewed the article and approved the final version.
Thank you to Alicia Livinski, from the NIH Library, for conducting the literature review searches.
Special thanks to all who gave valued input to the HIV/NCD project by participating in one or more products or meetings: James Alaro, Charles Ajayi, Ashley Antoine, Moses Bateganya, Kevin Brady, Pim Brouwers, Gene Bukhman, Hannah Cooper, Amisha Gandhi, Berhanu Molla Gedefaw, Roger Glass, Peter Godfrey-Faussett, Chris Gordon, Maureen Goodnow, Greg Greenwood, Joon Ha, Diane Havlir, Mark Hawkin, Degu Jerene, Jill Kanaley, Ben Kasdan, Peter Kilmarx, Elke Konings, Jeremiah Laktabai, Peter Lamptey, Fleetwood Loustalot, Carol Macera, Ellis McKenzie, Kathleen Michels, Collins Mitambo, Kibachio Jose Mwangi, Denis Nash, Funmi Olopade, Oyere Onuma, Nancy Padian, Gloria Sangiwa, Mona Saraiya, Virginia Senkomago, Arthur Sherman, George Siberry, Abraham Siika, Michael Smalky, Shelley Smith, Jason Sreedhar, Lindsay Templin, Marco Vitoria, David Watkins, Jessica Wilkinson, May Wong, and Emily Wroe.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US government.
Source of support: this article as part of the Research to Guide Practice: Enhancing HIV/AIDS Platform to Address Non-Communicable Diseases in sub-Saharan Africa was supported by the US National Institutes of Health Fogarty International Center.
Conflicts of interest
There are no conflicts of interest.
1. UNAIDS. Ending AIDS: progress towards the 90–90–90 targets
. Geneva: UNAIDS; 2017.
2. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
3. Goulet JL, Fultz SL, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?
. Clin Infect Dis
4. Smit M, Olney J, Ford NP, Vitoria M, Gregson S, Vassall A, et al. The growing burden of noncommunicable disease among persons living with HIV in Zimbabwe
5. Daniels MEDT, Bollyky T J. The emerging global health crisis: noncommunicable diseases in low- and middle-income countries
. New York: Council on Foreign Relations; 2014.
6. Joint United Nations Programme on HIV
/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2013. In: Joint United Nations Programme on HIV
/AIDS (UNAIDS); 2013.
7. World Health Organization. Clinical guidance across the continuum of care: managing common coinfections and comorbidities. In. Edited by Organization WH; 2013.
8. Suhrcke M, Boluarte TA, Niessen L. A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries
. BMC Public Health
9. Strand KB, Chisholm D, Fekadu A, Johansson KA. Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis
. Health Policy Plan
10. Sikander S, Lazarus A, Bangash O, Fuhr DC, Weobong B, Krishna RN, et al. The effectiveness and cost-effectiveness of the peer-delivered Thinking Healthy Programme for perinatal depression in Pakistan and India: the SHARE study protocol for randomised controlled trials
11. Scanlon PH, Aldington SJ, Leal J, Luengo-Fernandez R, Oke J, Sivaprasad S, et al. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
. Health Technol Assess
12. Rubinstein AL, Irazola VE, Poggio R, Gulayin P, Nejamis A, Beratarrechea A. Challenges and opportunities for implementation of interventions to prevent and control CVD in low-resource settings: a report from CESCAS in Argentina
. Glob Heart
13. Gaziano T, Abrahams-Gessel S, Surka S, Sy S, Pandya A, Denman CA, et al. Cardiovascular disease screening by community health workers can be cost-effective in low-resource countries
. Health Aff
14. Durao S, Ajumobi O, Kredo T, Naude C, Levitt NS, Steyn K, et al. Evidence insufficient to confirm the value of population screening for diabetes and hypertension in low- and-middle-income settings
. S Afr Med J
15. Denny L, Prendiville W. Cancer of the cervix: early detection and cost-effective solutions
. Int J Gynaecol Obstet
2015; 131 (Suppl 1):S28–S32.
16. Campos NG, Castle PE, Wright TC Jr, Kim JJ. Cervical cancer screening in low-resource settings: a cost-effectiveness framework for valuing tradeoffs between test performance and program coverage
. Int J Cancer
17. Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies
. Health Info Libr J
18. El-Sadr WM, Goosby E. Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV
2018; 32 (Suppl. 1):S1–S3.
19. WHO, WHO. STEPwise approach to surveillance (STEPS)
20. Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. for the NIH HIV
/NCD Project Disease Condition Technical Operating Group. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis
2018; 32 (Suppl. 1):S5–S20.
21. Nishtar S. The NCDs cooperative: a call to action
22. Rabkin M, de Pinho H, Michaels-Strasser S, Naitore D, Rawat A, Topp SM. Strengthening the health workforce to support integration of HIV and noncommunicable disease services in sub-Saharan Africa
2018; 32 (Suppl. 1):S47–S54.
23. Pastakia SD, Tran DN, Manji I, Wells C, Kinderknecht K, Ferris R. Building reliable supply chains for noncommunicable disease commodities: lessons learned from HIV and evidence needs
2018; 32 (Suppl. 1):S55–S61.
24. Juma K, Reid M, Roy M, Vorkoper S, Temu TM, Levitt NS, et al. From HIV prevention to non-communicable disease health promotion efforts in sub-Saharan Africa: A Narrative Review
2018; 32 (Suppl. 1):S63–S73.
25. Njuguna B, Vorkoper S, Patel P, Reid MJA, Vedanthan R, Pfaff C, et al. Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps
2018; 32 (Suppl. 1):S33–S42.
26. Nugent R, Barnabas RV, Golovaty I, Osetinsky B, Roberts DA, Bisson C, et al. Costs and cost-effectiveness of HIV/noncommunicable disease integration in Africa: from theory to practice
2018; 32 (Suppl. 1):S83–S92.
27. Mwagomba BLM, Ameh S, Bongomin P, Juma PA, Kyobutungi C, MacKenzie RK, et al. Opportunities and challenges for evidence-informed HIV-noncommunicable disease integrated care policies and programs: lessons from Malawi, South Africa, Swaziland and Kenya
2018; 32 (Suppl. 1):S21–S32.
28. Johnson M, Wilkinson J, Gardner A, Kupfer LE, Kimaiyo S, Von Zinkernagel D. Global partnerships to support noncommunicable disease care in low and middle-income countries: lessons from HIV/AIDS
2018; 32 (Suppl. 1):S75–S82.
29. Kemp CG, Weiner BJ, Sherr KH, Kupfer LE, Cherutich PK, Wilson D, et al. Implementation science for integration of HIV and non-communicable disease services in sub-Saharan Africa: a systematic review
2018; 32 (Suppl. 1):S93–S105.
30. National Cancer Institute. RFA-CA-15-007: planning for regional centers of research excellence in noncommunicable diseases in low and middle income countries (P20)
. Bethesda, MD: National Institutes of Health; 2016.
31. Fogarty International Center. RFA-TW-16-002: international research training grants: fogarty global health training program (D43)
. Bethesda, MD: National Institutes of Health; 2016.
32. National Heart Lung and Blood Institute. NOT-HL-17-520: notice of intent to publish a funding opportunity announcement for heart, lung, and blood co-morbidities implementation models in people living with HIV (HLB SIMPLe) (U01)
. Bethesda, MD: National Institutes of Health; 2017.
* Susan Vorkoper and Linda Kupfer listed as cofirst authors.
† HIV/NCD Project Members: Melanie Bacon, Joshua Berman, Rick Berzon, Pido Bongomin, Andrew Bremer, Delivette Castor, Pamela Collins, Rebecca Dirks, Geraldina Dominguez, Atalay Alem Ejigu, Michael Engelgau, Mychelle Farmer, John Flanigan, Eric Goosby, Rebecca Henry, Meghan Huchko, Michael Johnson, Kenneth Juma, Carol Langley, Naomi Levitt, George Mensah, Beatrice Matanje-Mwagomba, Helen McGuire, Paolo Miotti, Bernardo Nuche-Berenguer, Rachel Nugent, Paul Park, Sonak Pastakia, Emmanuel Peprah, Miriam Rabkin, Doreen Ramogola-Masire, Dianne Rausch, Michael Reid, Vikrant Sahasrabuddhe, Carolyn Williams, Makeda Williams, Deborah von Zinkernagel, Gerald Yonga.